2008
DOI: 10.1517/14740338.7.3.295
|View full text |Cite
|
Sign up to set email alerts
|

Hypersensitivity reactions to cephalosporins

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
20
0
2

Year Published

2009
2009
2019
2019

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 39 publications
(23 citation statements)
references
References 47 publications
0
20
0
2
Order By: Relevance
“…For example, cephalosporin and penicillin can cause significant cross-reactivity. 14 In the case of nilotinib and imatinib, however, nonhematologic cross-intolerance leading to discontinuation did not occur. None of the 75 patients with grade 3/4 or persistent grade 2 nonhematologic toxicity during imatinib therapy required a dose reduction or discontinuation of nilotinib because of the same AE, and only 1 patient experienced grade 3/4 toxicity of the same nature (diarrhea).…”
Section: Discussionmentioning
confidence: 98%
“…For example, cephalosporin and penicillin can cause significant cross-reactivity. 14 In the case of nilotinib and imatinib, however, nonhematologic cross-intolerance leading to discontinuation did not occur. None of the 75 patients with grade 3/4 or persistent grade 2 nonhematologic toxicity during imatinib therapy required a dose reduction or discontinuation of nilotinib because of the same AE, and only 1 patient experienced grade 3/4 toxicity of the same nature (diarrhea).…”
Section: Discussionmentioning
confidence: 98%
“…Cephalosporins are currently one of the most widely prescribed antibiotics along with penicillins, because of their broad spectrum of activity on both gram‐positive and gram‐negative bacteria . The therapeutic use of cephalosporins has been increasing since the 1990s, and reports of hypersensitivity reactions to cephalosporins are also increasing.…”
mentioning
confidence: 99%
“…Newer cephalosporins such as cefuroxime, ceftazidime, ceftriaxone are unlikely to be associated with cross-reactivity because of differences in chemical structure and do not appear to pose the same level of risk 39. Nevertheless, immunologist/allergist evaluation is strongly recommended where possible 41. A clinician faced with a patient with possible penicillin allergy has a number of options (figure 2).…”
Section: Introductionmentioning
confidence: 99%